Aqtual
Aqtual is a biotechnology diagnostics platform that provides healthcare solutions, novel technology, and biochemistry for chronic disease. The company utilizes a novel cell-free DNA-based platform that evaluates protein regulation, epigenetics, and transcriptomics solely using cell-free DNA fragments found in the blood. The platform also yields efficient and robust real-time analysis of disease and treatment while overcoming the limitations of previous cell-free DNA methodologies.
Domain
aqtual.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$31.0M
Founded
2017
Tech Stack (7 technologies)
Frequently Asked Questions
What technologies does Aqtual use?+
Aqtual uses 7 technologies including Nuxt.js, core-js, Webpack.
What industry is Aqtual in?+
Aqtual operates in the Biotechnology industry.
Where is Aqtual based?+
Aqtual is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026